Clinical Report: Mining the Literature for Bioprocess Gains

Overview

An integrated framework utilizing text mining and knowledge graph modeling has been developed to optimize biopharmaceutical processes. This system extracts structured information from literature, linking key process parameters to outcomes, thereby enhancing data organization and interpretation for process development.

Background

The optimization of biopharmaceutical processes is critical for improving yield, productivity, and product quality. Despite the abundance of data in scientific literature, synthesizing findings across studies is often labor-intensive. The application of automated text extraction and knowledge graph modeling can streamline this process, facilitating better decision-making in biopharmaceutical manufacturing.

Data Highlights

No numerical data available in the source material.

Key Findings

• The framework integrates text mining with knowledge graph modeling to support biopharmaceutical process optimization.
• Key process parameters such as temperature, pH, and nutrient levels were linked to outcomes like protein expression and product quality.
• The system allows users to query relationships between process variables and outcomes, enhancing transparency and data accessibility.
• Case examples demonstrated the framework's application in monoclonal antibody manufacturing.
• Variability in terminology across studies may impact the effectiveness of entity recognition and relationship mapping.
• The framework is intended to assist with literature review and experimental planning, rather than replace experimental validation.

Clinical Implications

Detail potential integration strategies for the framework into existing workflows.

Conclusion

Identify specific areas for further evaluation to improve integration into workflows.

References

1. the medicine maker, The Medicine Maker, 2026 -- Machine Learning Enables Real-Time Bioprocess Optimization
2. the medicine maker, The Medicine Maker, 2026 -- AI and the Future of Bioprocess Labs
3. Updates in Surgery, Updates in Surgery, 2025 -- Analysis of Bibliometric Trends in the Use of Artificial Intelligence in Gastrointestinal Surgery Over the Past Decade
4. npj Digital Medicine, npj Digital Medicine, 2025 -- Machine Learning and Network Toxicology Approaches for Computational Pharmacovigilance of Lifitegrast in Managing Dry Eye Disease
5. Artificial intelligence | European Medicines Agency (EMA), EMA, 2026 -- AI in Medicines Development
6. FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs | FDA, FDA, 2025 -- Accelerating Biosimilar Development
7. Artificial intelligence | European Medicines Agency (EMA)
8. FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs | FDA
9. Biosimilar switching in IBD: safety, efficacy, and immunogenicity in 10,812 patients - A systematic review and meta-analysis - PubMed